Related Experiment Videos
Diagnostic Notch3 sequence analysis in CADASIL: three new mutations in Dutch patients. Dutch CADASIL Research Group
S A Oberstein1, M D Ferrari, E Bakker
1Department of Clinical Genetics, Leiden University Medical Center, The Netherlands.
Insights
Directly analyzing the Notch3 gene confirmed diagnoses for Dutch patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). This genetic testing is a feasible diagnostic approach for CADASIL.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a rare genetic disorder.
- Accurate clinical diagnosis is crucial for patient management and genetic counseling.
Purpose of the Study:
- To evaluate the utility of direct Notch3 gene sequencing for confirming CADASIL diagnoses in Dutch patients.
- To identify novel mutations within the Notch3 gene associated with CADASIL.
Main Methods:
- Direct sequence analysis of the Notch3 gene was performed on patients from 11 families.
- Genetic analysis focused on identifying missense mutations, particularly those affecting cysteine residues.
Main Results:
- Eleven missense mutations in the Notch3 gene were identified, including three previously unreported mutations.
- Exon 4 of the Notch3 gene was identified as a mutation hotspot, implicated in 9 out of 11 families studied.
- Direct sequence analysis proved to be a feasible method for confirming CADASIL diagnoses.
Conclusions:
- Direct Notch3 gene sequencing is an effective method for confirming clinical diagnoses of CADASIL in individual patients.
- The findings highlight the importance of Notch3 gene mutations in the pathogenesis of CADASIL.
- Identification of novel mutations expands the known mutational spectrum of CADASIL.
Abstract:
To confirm the clinical diagnosis in individual Dutch patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), we performed direct sequence analysis of the abnormal gene, Notch3, in patients from 11 families without prior linkage analysis to chromosome 19. Eleven missense mutations involving the loss or gain of a cysteine residue were found, of which 3 are new. Exon 4 is a mutation hotspot (9 of 11 families). Notch3 sequence analysis of CADASIL patients in a diagnostic laboratory is a feasible procedure to confirm the clinical diagnosis in individual patients.